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Title: .	Point-of-care HCV RNA screening by finger-prick is technically feasible but uptake is reduced by concomitant offer of HIV testing
Please do not add the names of authors or affiliations on this formUse a concise title that indicates the nature of the study.Please capitalise the first letter of the title and use lower case for the rest of the title (with the exception of proper nouns or abbreviations).e.g. Recall of men who have sex with men diagnosed with bacterial sexually transmitted infections for retesting: a feasible and effective strategy?  Please do not use a full stop at the end of the title

Abstract:
Your abstract must be pasted into the space to the right and use the Arial font in size 10. Your abstract must not exceed a maximum of 2,500 characters (including spaces and tables).Please follow the general outline Background, Methods, Results and Conclusion where applicable.Please ensure that your abstract is thoroughly proof read for grammatical inaccuracies.	Background: Eliminating hepatitis C as a public health threat by 2030 has been set as a priority by the World Health Organisation. Improving offer and uptake of HCV screening is a central component of the strategy. This study investigated the feasibility of offering point-of-care testing (POCT) for HCV in an inner-city accidence and emergency (A&E) department using a pre-validated method for detecting viral RNA in finger-prick blood, and to assess the influence on uptake of offering concomitant POCT for HIV. Methods: Following extensive technical validation studies, the innovative testing method was based on the detection of HCV RNA and HIV-1 RNA in small-volume capillary blood collected by finger-prick using the Cepheid GeneXpert platform, with a turnaround time of 90 minutes. Over a period of six months, all adults attending A&E with minor injuries throughout 24 hours were invited to complete an anonymous questionnaire and offered POCT. Distinct, alternating cycles of offering screening for HCV alone or for both HCV and HIV together were implemented. The main outcome measures were: 1) among questionnaire respondents, proportion that accepted or declined HCV POCT, and 2) influence of concomitant offer of HIV screening on POCT uptake.Results: Overall, 814/859 (94.8%) questionnaires were returned and 324/814 (39.8%) test offers were accepted, comprising 211 HCV tests and 113 HCV+HIV tests. Respondents were predominantly aged 18-54 years (647/814, 79.5%) and of self-reported white ethnicity (725/814, 89.1%), with equal proportions of men and women. Most POCT participants (260/324, 80.3%) elected to receive the results by text message rather than wait. After adjusting for age and knowledge of HCV status, offering concomitant HIV screening was associated with a 50% decline in POCT uptake (adjusted odds ratio 0.51; 95% confidence interval [CI] 0.38-0.68; p<0.001). HCV prevalence was 1/324 (0.31%; 95% CI 0.05-1.73). No participant tested positive for HIV (prevalence 0.0%; 95% CI 0.0%-1.17).Conclusions: Whilst implementation of HCV RNA screening at point-of-care was technically feasible, uptake was moderate and the simultaneous offer of HIV screening appeared to have a detrimental impact on acceptability. This finding appears to suggest persistent stigma surrounding HIV testing and bears implication for the design of screening programmes. It should be confirmed in other settings. 
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